| Nolte, Andreas (Märzhäuser 201608– Managing Director at Märzhäuser Wetzlar GmbH & Co KG before Carl Zeiss) |
Managing Director |
Märzhäuser (Group) |
Germany |
| Nominacher, Bastian (Celonis 202106 Co-CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Celonis (Group) |
Germany |
| Nomura, Hiroshi (Sumitomo 201910 CEO of Sumitomo Dainippon Pharma) |
Chief Executive Officer (CEO) |
Sumitomo (Group) |
Japan |
| Nonell-Canals, Alfons (Mind the Byte 2011– CEO + Founder) |
Chief Executive Officer (CEO) |
Mind the Byte (Group) |
Spain (España) |
| Nonhoff, Offer (Pixium Vision 202106– CFO before Trigo + Lumenis + BoneSupport + Fresenius Medical Care Israel) |
Chief Financial Officer (CFO) |
Pixium Vision S.A. |
France |
| Nonomura, Kazuhika (Remiges Ventures 202209 Principal) |
Principal (venture capital) |
Remiges Ventures |
United States (USA) |
| Noonan, Mo (Mo PR Advisory 202005– Founder before 21y at FTI Consulting) |
Public Relations Manager / Investor Relations Manager |
Mo PR Advisory Ltd. |
United Kingdom (GB) |
| Noonan, Rebecca (Optimum Stratetic Communications 202206) |
Public Relations Manager / Investor Relations Manager |
Optimum Strategic Communications |
United Kingdom (GB) |
| Noonan, Susan A. (S.A. Noonan Communications before Noonan/Russo Communications) |
Public Relations Manager / Investor Relations Manager |
S.A. Noonan Communications – Susan A. Noonan |
United States (USA) |
| Noone, Philip (Aalto Bio Reagents 202205 CEO) |
Chief Executive Officer (CEO) |
Biosynth (since 9/22) (Group) |
Ireland, Republic of |
| Noorem, Toomas (Tartu Science Park 201110 Managing Director) |
Managing Director |
Tartu Science Park Foundation |
Estonia |
| Nordheim, Alfred (Univ Tübingen 200809) |
Professor |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Nordhof, Eckard |
n. a. |
Bico (Group) |
Germany |
| Nordhoff, Henry L. (Hank) ((Gen-Probe 200905 non-exec Board Chairman before CEO since 1994) |
Board member, non-executive |
Hologic (Group) |
United States (USA) |
| Nordkild, Peter (Adenium Biotech 2011– CEO before Egalet CEO before Pharmexa COO before Ferring Senior VP) |
Chief Executive Officer (CEO) |
Adenium Biotech ApS |
Denmark |
| Nordlander, Rune (Sprint Bioscience 201906 Board Chairman) |
Board member, non-executive |
Sprint Bioscience AB |
Sweden |
| Nordmann, Carsten (Biomol GmbH 201108 Managing Director) |
Managing Director |
Biomol GmbH (DE) |
Germany |
| Nordstedt, Christer (Oblique Therapeutics 202311 CEO before Vivesto) |
Chief Executive Officer (CEO) |
Oblique Therapeutics AB (publ) |
Sweden |
| Norgaard, Jens Viktor (Symphogen 200705 Director IP) |
IP Manager |
Servier (Group) |
Denmark |
| Norgren, Niklas (UmanDiagnostics 201906 CEO) |
Chief Executive Officer (CEO) |
Quanterix (Group) |
Sweden |
| Norlén, Per (Alligator Bioscience –202103 CEO) |
Chief Executive Officer (CEO) |
Alligator Bioscience (Group) |
Sweden |
| Norman, John (Optibrium 202002 Head of Marketing) |
Sales Manager / Marketing Manager |
Optibrium (Group) |
United Kingdom (GB) |
| Normington, Karl (Sirtris 200611 Director Intellectual Property) |
IP Manager |
GSK (Group) |
United States (USA) |
| Norrey, Martin (European Spectrometry Systems founder) |
Company Founder |
European Spectrometry Systems Ltd. (ESS) |
United Kingdom (GB) |
| Norris, Jeremy (Protein Discovery 201003 VP RnD) |
Research & Development Manager |
2invest (Group) |
United States (USA) |
| Norstedt, Irene (IMI 201502 Acting Executive Director) |
President/Director/Head Business Group/Unit/Division |
Innovative Health Initiative (IHI JU) |
EU (European Union) |
| Norström, Erik (Tecan 201712c– Head of Corporate Development before Chr Hansen + Nobel Biocare + Roche) |
Business Development Manager / Strategy Manager |
Tecan (Group) |
Switzerland |
| Northage, Alan (Shimadzu 201112 Shimadzu UK GC/GCMS Business Manager) |
Product Manager (personnel) |
Shimadzu (Group) |
United Kingdom (GB) |
| Northoff, Stefan (TeutoCell 201105 Executive Board Member) |
Board member, executive |
Xell AG |
Germany |
| Norwood, Brad (Molins 201105 Director of Arista Laboratories) |
Managing Director |
Molins (Group) |
United States (USA) |
| Norwood, David (IP2IPO 200506 CEO) |
Chief Executive Officer (CEO) |
IP Group (Group) |
United Kingdom (GB) |
| Nota, Pieter (Philips –201707 Chief Buiness leader Personal Health business + Chief Marketing Officer LEFT 7/17) |
Chief Business Officer (CBO) |
Philips (Group) |
Netherlands |
| Nothelfer, Katharina (AiCuris 202308 Public Relations) |
public relations / investor relations |
STRÜNGMANN Group (family Strüngmann) |
Germany |
| Nothias, Jean-Yves (Amundi 201107 Managing Partner Life Sciences before Société Générale Managing Director Biotech VC) |
Managing Partner (investment firm) |
Amundi (Group) |
France |
| Nottrott, Stephanie (Isenbruck Bösl Hörschler 201511 Patent Attorney) |
Patent Attorney |
Isenbruck | Bösl | Hörschler LLP |
Germany |
| Nour, Afif Abdel (Stilla Technologies 202402– VP of Global Marketing before Qiagen + Bio-Rad) |
Sales Manager / Marketing Manager |
Stilla Technologies (Group) |
France |
| Novak, Filip (Qiagen Hamburg 200608 Manager Regulatory Compliance) |
Regulatory Affairs Manager |
Qiagen (Group) |
Germany |
| Novak, Lidia (Biognosys 2019089 CFO) |
Chief Financial Officer (CFO) |
Bruker (Group) |
Switzerland |
| Novak, Rodger (CRISPR Therapeutics 201712– Board Chairman 2013–201711 CEO + Co-Founder before Sanofi + Nabriva GmbH) |
Board member, non-executive |
CRISPR Therapeutics (Group) |
Switzerland |
| Novak, Terry (DSM Biologics 200701 Business Director + Chief Marketing Officer) |
Business Development Manager / Strategy Manager |
DSM (Group) |
Netherlands |
| Novakovic, Nela (BetaSense 202301 Managing Director (COO)) |
Chief Operating Officer (COO) |
BetaSense GmbH |
Germany |
| Novo, David (De Novo Software 201111 President) |
President/Director/Head Business Group/Unit/Division |
Insightful Science (Group) |
United States (USA) |
| Novorol, Claire (Ada Health 201712 CMO + Co-Founder) |
Chief Medical Officer (CMO) |
Ada Health (Group) |
Germany |
| Novoselov, Kostya (Univ Manchester 201504 Nobel Prize for Physics in 2010) |
Professor |
University of Manchester, National Graphene Institute (NGI) |
United Kingdom (GB) |
| Novy, Karel (Biognosys 202101– promoted to COO joined 2016 before Monash Univ + ETH Zürich) |
Chief Operating Officer (COO) |
Bruker (Group) |
Switzerland |
| Nowack, Björn (SensID GmbH 201905 Managing Director (CEO) + Co-Founder) |
Chief Executive Officer (CEO) |
SensID GmbH |
Germany |
| Nowak, Lukasz (Selvita 202203– COO of Ardigen) |
Business Development Manager / Strategy Manager |
Selvita (Group) |
Poland |
| Nowak, Michael J. (Yorkville 201108 Managing Director of Yorkville Advisors LLC) |
Managing Director |
Yorkville Group (Group) |
United States (USA) |
| Nowers, Chris (Cell Medica 201808– CEO before Kite Pharma 201610– Head of Europe before BMS + Genomic Health) |
Chief Executive Officer (CEO) |
Athenex (Group) |
United Kingdom (GB) |
| Noyes, Catherine (GeneBio 201008 Marketing Manager) |
Sales Manager / Marketing Manager |
GeneBio (Group) |
Switzerland |
| Nuechterlein, Carole (Roche 201604 Head of Roche Venture Fund) |
Investment Manager |
Roche (Group) |
Switzerland |
| Nuernberger, Falk (Rentschler 202207– Corporate General Counsel before Viatris + MediGene + Sandoz + Actavis) |
General Counsel / Chief Legal Officer (CLO) |
Rentschler (Group) |
Germany |
| Nugent, Kerry (Michrom 201008 President + founder) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
| Nui, Zhangming (MindRank 202309 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
MindRank (Group) |
China |
| Nukal, Balaji (SeedWorks India 201506 Managing Director) |
Managing Director |
Bayer (Group) |
India |
| Núnez-Garcia, Sara (Forty51 Advisors 202204– Partner + Co-Founder formerly Sofinnova Partners 201410 Associate) |
Partner (venture partner) |
Forty51 Ventures (Group) |
Switzerland |
| Nunn, Simon (Thermo Fisher 201308 Global Marketing Director Molecular Spectroscopy) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
United States (USA) |
| Nurmi, Virve (Biotie 201110 Investor Relations Manager) |
Public Relations Manager / Investor Relations Manager |
Acorda Therapeutics (Group) |
Finland |
| Nurse, Paul (Francis Crick Institute 201602 Director) |
President/Director/Head of Research Organisation/Unit |
Francis Crick Institute Ltd., The |
United Kingdom (GB) |
| Nussbaum, Ran (Pontifax 200712 Managing Partner also CEO of Biomedix Incubator) |
Managing Partner (investment firm) |
Pontifax (Group) |
Israel |
| Nussbaumer, Oliver (GammaDelta Therapeutics Co-Founder) |
Company Founder |
Takeda (Group) |
United Kingdom (GB) |
| Nussbaumer, Peter (Max Planck 201104 Managing Director of Lead Discovery Center GmbH) |
Managing Director |
Max Planck Society for the Advancement of Science |
Germany |
| Nuttall, Mark E. (Kintai Therapeutics 201909– CBO before Kymera Therapeutics + Sanofi Genzyme + JnJ Innovation) |
Chief Business Officer (CBO) |
Kintai Therapeutics Inc. |
United States (USA) |
| Nutzhorn, Christa (Cytocentrics 200809 CEO) |
Chief Executive Officer (CEO) |
NONE |
Germany |
| Nuwaysir, Emile (Bayer 201904 CEO of BlueRock Therapeutics) |
Chief Executive Officer (CEO) |
Bayer (Group) |
United States (USA) |
| Nygaard, Geert Walther (Epigenomics 200702–201209 CEO LEFT 9/12 before Abbott GmbH + Dako + Beckman) |
Chief Executive Officer (CEO) |
Epigenomics (Group) |
Germany |
| Nygård, Mikael (Vicore Pharma 202111– VP of Business Development before Humana AB + Boston Consulting Group) |
Business Development Manager / Strategy Manager |
Vicore Pharma (Group) |
Sweden |
| Nürnberger, Christian (TO DO Life Sciences 201108 Managing Director) |
Managing Director |
TO DO Life Sciences (Group) |
Germany |
| Nüsslein-Vollhard, Christiane |
n. a. |
Taconic (Group) |
Germany |
| Nystroem, Katarina (GATC 200803– Sales Manager Stockholm) |
Sales Manager / Marketing Manager |
Eurofins (Group) |
Germany |
| Nyström, Mattias (APL 201608 Business Development Manager) |
Business Development Manager / Strategy Manager |
APL (SE) (Group) |
Sweden |
| Nüßlein, Bernd (nadicom 200503 General Manager + founder) |
General Manager (management) |
Nadicom – Gesellschaft für angewandte Mikrobiologie mbH |
Germany |
| Näder, Hans Georg (Ottobock 201706 President + major shareholder + grandson of Otto Bock) |
Managing Director |
Ottobock (Otto Bock) (Group) |
Germany |
| Nägler, Karl (Wellington Partners 202001– Managing Partner before Gimv + Ventech + Atlas Venture) |
Partner (venture partner) |
Wellington Partners (Group) |
Germany |
| Närhi, Jari (Nadmed 202402 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Nadmed Oy |
Finland |
| Næss-Ulseth, Eirik (Spermatech 200803 CEO) |
Chief Executive Officer (CEO) |
Spermatech AS |
Norway |
| Näsström, Jacques |
n. a. |
Karolinska Investment Fund |
Sweden |
| Näveke, Arne (Consilium 202303– Senior Strategic Advisor + head of US before Freeline Therapeutics + Alexion + GSK) |
Public Relations Manager / Investor Relations Manager |
ICR (Group) |
United States (USA) |
| Nörenberg, Astrid (Upcyte Technologies GmbH 201507– Managing Director + Founder) |
Managing Director |
Upcyte Technologies GmbH |
Germany |
| Nörtershauser, Jens (Kranus Health 202206 Co-CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Kranus Health (Group) |
Germany |
| Nöthen, Markus (Life & Brain 201912 Managing Director) |
Managing Director |
Life & Brain GmbH |
Germany |
| Nößner, Elfriede (Helmholtz 201901 Professor + Head of Immunoanalytics at Helmholtz-Zentrum München) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| O'Brien, Elaine (Camena Bioscience 202307 Head of Marketing before Horizon Discovery) |
Sales Manager / Marketing Manager |
Camena Bioscience Ltd. |
United Kingdom (GB) |
| O'Day, Daniel (Gilead 201903 CEO before Roche Pharma CEO + COO + Roche Diagnostics COO joined Roche 1987) |
Chief Executive Officer (CEO) |
Gilead Sciences (Group) |
United States (USA) |
| O'Kelly, Stafford (Abbott 200803 VP Molecular Diagnostics) |
n. a. |
Abbott (Group) |
United States (USA) |
| Oakes, Christopher (SynBioBeta LLC 201702 Business Development Manager) |
Business Development Manager / Strategy Manager |
SynBioBeta LLC |
United States (USA) |
| Oakes, Frank (Stellar Biotechnologies 201605 CEO) |
Chief Executive Officer (CEO) |
Stellar Biotechnologies Inc. (Nasdaq: SBOT, TSX Venture: KLH) |
United States (USA) |
| Oakland, Simon Nicholas (Biofusion 200604 non-exec Director) |
Board member, non-executive |
Fusion IP (Group) |
United Kingdom (GB) |
| Oakley, Andrew J. (Autolus 201806– CFO before Sosei + Vectura + Novimmune + Actelion) |
Chief Financial Officer (CFO) |
Autolus Therapeutics plc (Nasdaq: AUTL) |
United Kingdom (GB) |
| Oakman, Colin (Healx 201807 Finance Director) |
Chief Financial Officer (CFO) |
Healx Ltd. |
United Kingdom (GB) |
| Obama, Barack (United States (govt) 2008 President) |
Governmental Officer (personnel) |
United States (govt) |
United States (USA) |
| Obbad, Kamal (Nebula Genomis 201808 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Nebula Genomics (US) |
United States (USA) |
| Obenshain, Andrew (Bluebird Bio 201612– Head of Europe before Shire in Paris + Sanofi + Genzyme) |
Regional manager |
Bluebird Bio (Group) |
France |
| Ober, Mario (IBFB Pharma 200502 Investment Director + Chairman Supervisory Board) |
Investment Manager |
Novartis (Group) |
Germany |
| Oberacher, Herbert (Medical Univ Innsbruck 201110 Assistant Prof at Institute of Legal Medicine) |
Assistant Professor / Associate Professor |
Medical University Innsbruck (MUI) |
Austria |
| Oberheitmann, Boris (Q-Bioanalytic Managing Director + co-founder + Sequid 2007–201007 Managing Director) |
Managing Director |
Eurofins (Group) |
Germany |
| Oberholz, Alfred (VCI 200808 chairman) |
n. a. |
VCI (Verband der Chemischen Industrie e. V.) |
Germany |
| Oberhänsli, Walter (Zur Rose Group 202007 CEO) |
Chief Executive Officer (CEO) |
Zur Rose Group (Group) |
Switzerland |
| Oberländer, Monique (CCS Cell Culture Service 201105) |
n. a. |
Evotec (Group) |
Germany |
| Oberländer, Uwe (Roche Diagnostics GmbH 200703 Leiter Marketing Labordiagnostik) |
n. a. |
Roche (Group) |
Germany |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 ... 107 108 109 ... 166 167 168 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
